Hutch News

Hutch News

Stories tagged 'aromatase inhibitor'

Integrative oncology program opens at SCCA

Research and rigor will guide integrative therapies that help cancer patients tolerate standard treatment

Nov. 1, 2018 | By Diane Mapes / Fred Hutch News Service

Cancer patients can now receive acupuncture and other integrative therapies to help them deal with the side effects of treatment through the SCCA’s new Integrative Medicine Program, headed by Hutch researcher Dr. Heather Greenlee.

View story >


Acupuncture can curb treatment-related joint pain in breast cancer patients

Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug

July 10, 2018 | By Diane Mapes / Fred Hutch News Service

Results from a large multicenter trial published today in JAMA offer good news to early stage breast cancer patients dealing with painful side effects from powerful estrogen-squelching drugs known as aromatase inhibitors.

View story >


Potentially 'powerful tool' for noninvasive cancer treatment assessment

Linden and colleagues find PET scans can provide accurate, early assessment of response to breast-cancer therapy

June 1, 2009 | By Dean Forbes

Dr. Hannah Linden of the Seattle Cancer Care Alliance and colleagues discovered the response of patient's with estrogen receptor positive breast cancer to standard aromatase-inhibitor therapy can be measured by noninvasive imaging with similar results to invasive needle sampling.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.